The influence of liver metastases on the pharmacokinetics of doxorubicin---a population-based pharmacokinetic project of the CESAR-APOH.
Müller
H J
HJ
Department of Physiological Chemistry, University of Marburg, Germany. muellerb@mailer.uni-marburg.de
Port
R E
RE
Grubert
M
M
Hilger
R A
RA
Scheulen
M
M
Mross
K
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000378:metabolism / Q000493:pharmacokinetics*; D001219:Aspartate Aminotransferases / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000009:adverse effects / Q000378:metabolism / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000556:secondary*; D008297:Male; D008875:Middle Aged
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; D001219:Aspartate Aminotransferases